Using Proteomics to Determine Key to Embryo Implantation Success
A new study presents a proteomics approach to investigate changes at the molecular scale that could control whether or not embyro implantation using IVF is successful.
There are many couples worldwide that are affected by infertility and require medical intervention to achieve a successful pregnancy. In vitro fertilization–embryo fertilization (IVF–ET) is one procedure that can be undergone; however, it can be limited by the low rate of embryo implantation. A new study published in the Journal of Proteome Research presents a proteomics approach to investigate changes at the molecular scale that could control whether or not implantation using IVF is successful.1
The authors state that around two-thirds of implantation failures in IVF are attributed to the receptivity of the membrane lining the uterus, the endometrium, which is a complex tissue that undergoes changes in response to hormone levels in the body. To detect the changes governing receptivity, the authors took a proteomics approach to screen for changes in proteins expressed in the tissue when receptive versus proliferative phase (non-receptive).
Clinical biopsy tissue samples were taken from 12 women undergoing IVF treatment and analyzed using high performance liquid chromatography coupled to tandem mass spectrometry (HPLC–MS–MS). More than 2000 proteins were identified and quantified - 300 proteins were found to vary between the receptive and proliferative phase. According to the authors, the method developed could be performed in future studies looking at variations in protein expression in other endometrium-related diseases.
Reference
1. Q. Chen et al., Journal of Proteome Research14, 1831–1842 (2015).
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
